BRCA1 Carriers and Oral Contraceptives - Risk-benefit Calculation on Breast and Ovarian Cancer

被引:0
|
作者
Schrijver, L. H. [1 ]
Rookus, M. A. [1 ]
Mooij, T. M. [1 ]
Pijpe, A. [1 ]
van Leeuwen, F. E. [1 ]
机构
[1] Netherlands Canc Inst, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S75 / S75
页数:1
相关论文
共 50 条
  • [31] Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers
    Hughes, DJ
    Ginolhac, SM
    Coupier, I
    Corbex, M
    Bressac-de-Paillerets, B
    Chompret, A
    Bignon, YJ
    Uhrhammer, N
    Lasset, C
    Giraud, S
    Hardouin, A
    Berthet, P
    Peyrat, JP
    Fournier, J
    Nogues, C
    Lidereau, R
    Muller, D
    Fricker, JP
    Longy, M
    Toulas, C
    Guimbaud, R
    Maugard, C
    Olschwang, S
    Yannoukakos, D
    Durocher, F
    Moisan, AM
    Simard, J
    Mazoyer, S
    Lynch, HT
    Szabo, C
    Lenoir, GM
    Goldgar, DE
    Stoppa-Lyonnet, D
    Sinilnikova, OM
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (01) : 265 - 267
  • [32] Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Peterlongo, Paolo
    Chang-Claude, Jenny
    Moysich, Kirsten B.
    Rudolph, Anja
    Schmutzler, Rita K.
    Simard, Jacques
    Soucy, Penny
    Eeles, Rosalind A.
    Easton, Douglas F.
    Hamann, Ute
    Wilkening, Stefan
    Chen, Bowang
    Rookus, Matti A.
    Schmidt, MarjankaK.
    van der Baan, Frederieke H.
    Spurdle, Amanda B.
    Walker, Logan C.
    Lose, Felicity
    Maia, Ana-Teresa
    Montagna, Marco
    Matricardi, Laura
    Lubinski, Jan
    Jakubowska, Anna
    Garcia, Encarna B. Gomez
    Olopade, Olufunmilayo I.
    Nussbaum, Robert L.
    Nathanson, Katherine L.
    Domchek, Susan M.
    Rebbeck, Timothy R.
    Arun, Banu K.
    Karlan, Beth Y.
    Orsulic, Sandra
    Lester, Jenny
    Chung, Wendy K.
    Miron, Alex
    Southey, Melissa C.
    Goldgar, David E.
    Buys, Saundra S.
    Janavicius, Ramunas
    Dorfling, Cecilia M.
    van Rensburg, Elizabeth J.
    Ding, Yuan Chun
    Neuhausen, Susan L.
    Hansen, Thomas V. O.
    Gerdes, Anne-Marie
    Ejlertsen, Bent
    Jonson, Lars
    Osorio, Ana
    Martinez-Bouzas, Cristina
    Benitez, Javier
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (01) : 308 - 316
  • [33] Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives
    Runnebaum, IB
    Wang-Gohrke, S
    Vesprini, D
    Kreienberg, R
    Lynch, H
    Moslehi, R
    Ghadirian, P
    Weber, B
    Godwin, AK
    Risch, H
    Garber, J
    Lerman, C
    Olopade, OI
    Foulkes, WD
    Karlan, B
    Warner, E
    Rosen, B
    Rebbeck, T
    Tonin, P
    Dubé, MP
    Kieback, DG
    Narod, SA
    PHARMACOGENETICS, 2001, 11 (07): : 635 - 638
  • [34] Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers
    Derks-Smeets, Inge A. P.
    Schrijver, Lieske H.
    de Die-Smulders, Christine E. M.
    Tjan-Heijnen, Vivianne C. G.
    van Golde, Ron J. T.
    Smits, Luc J.
    Caanen, Beppy
    van Asperen, Christi J.
    Ausems, Margreet
    Collee, Margriet
    van Engelen, Klaartje
    Kets, C. Marleen
    van der Kolk, Lizet
    Oosterwijk, Jan C.
    van Os, Theo A. M.
    Rookus, Matti A.
    van Leeuwen, Flora E.
    Gomez Garcia, Encarna B.
    BRITISH JOURNAL OF CANCER, 2018, 119 (03) : 357 - 363
  • [35] Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers
    Derks-Smeets, I.
    Schrijver, L.
    De Die-Smulders, C.
    Tjan-Heijnen, V.
    Van Golde, R.
    Caanen, B.
    Rookus, M.
    Van Leeuwen, F.
    Gomez-Garcia, E.
    HUMAN REPRODUCTION, 2018, 33 : 81 - 82
  • [36] Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers
    Inge A. P. Derks-Smeets
    Lieske H. Schrijver
    Christine E. M. de Die-Smulders
    Vivianne C. G. Tjan-Heijnen
    Ron J. T. van Golde
    Luc J. Smits
    Beppy Caanen
    Christi J. van Asperen
    Margreet Ausems
    Margriet Collée
    Klaartje van Engelen
    C. Marleen Kets
    Lizet van der Kolk
    Jan C. Oosterwijk
    Theo A. M. van Os
    Matti A. Rookus
    Flora E. van Leeuwen
    Encarna B. Gómez García
    British Journal of Cancer, 2018, 119 : 357 - 363
  • [38] Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Ramus, Susan J.
    Antoniou, Antonis C.
    Kuchenbaecker, Karoline B.
    Soucy, Penny
    Beesley, Jonathan
    Chen, Xiaoqing
    McGuffog, Lesley
    Sinilnikova, Olga M.
    Healey, Sue
    Barrowdale, Daniel
    Lee, Andrew
    Thomassen, Mads
    HUMAN MUTATION, 2012, 33 (04) : 690 - 702
  • [39] Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Kuchenbaecker, Karoline B.
    Hopper, John L.
    Barnes, Daniel R.
    Phillips, Kelly-Anne
    Mooij, Thea M.
    Roos-Blom, Marie-Jose
    Jervis, Sarah
    van Leeuwen, Flora E.
    Milne, Roger L.
    Andrieu, Nadine
    Goldgar, David E.
    Terry, Mary Beth
    Rookus, Matti A.
    Easton, Douglas F.
    Antoniou, Antonis C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (23): : 2402 - 2416
  • [40] Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
    Kuchenbaecker, Karoline B.
    McGuffog, Lesley
    Barrowdale, Daniel
    Lee, Andrew
    Soucy, Penny
    Dennis, Joe
    Domchek, Susan M.
    Robson, Mark
    Spurdle, Amanda B.
    Ramus, Susan J.
    Mavaddat, Nasim
    Terry, Mary Beth
    Neuhausen, Susan L.
    Schmutzler, Rita Katharina
    Simard, Jacques
    Pharoah, Paul D. P.
    Offit, Kenneth
    Couch, Fergus J.
    Chenevix-Trench, Georgia
    Easton, Douglas F.
    Antoniou, Antonis C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (07):